RE:How long must we wait You are suggesting that they should have delayed making an announcement until Plan B had been clearly elanorated....That would have been unfair to patients and unethical....I think patients interest must be prioritized over shareholders interest
Of course THTX will have to convince the market that they have a viable plan and the sooner the better but not at the expense of depth and well thought out
I wrote yesterday that what Paul does next will define his legacy .... not the fact that Sortilin Plaform might turn out to bena dud..
Garp1 wrote:
IMO, Paul was forced to come out with this announcement because of the new brokerage firm reports and the fact that he had told the market that news was coming in December. I believe He would of continued to hide the facts,if the brokerage firms had not produced any report. I also think that has a CEO and based on the information he told the markets he should have refrained form pursuing or even suggesting a revised trial plan whithout at least demonstrating the viability of such an option. A post-mortum analysis should have been proposed by Paul before even suggesting any continuance of the trial and he should have implemented all necessary cost cutting measures and strategic decisions to demonstrate is committement to protect the business, the shareholder and also indicated to the market that he was taking all measures required to recover and grow from this. This should have been done at the same time as the announcement. One must question at this stage if Paul represents the type of CEO that Thera needs right now.